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Letters
PERICARDIAL EFFUSION AND TAMPONADE 
COMPLICATING TREATED GRAVES’ 
THYROTOXOCOSIS
Editor, 
Pericardial  effusion  has  been  reported  in  Graves  disease. 
We report a case where symptoms of cardiac failure and the 
development of a symptomatic pericardial effusion were the 
predominant  manifestations  of  thyrotoxicosis  undergoing 
treatment.
Case Report: A 42 year old lady was admitted with a six-
week history of increasing shortness of breath. She described 
pleuritic chest pain and had recently noticed ankle oedema. 
She had no symptoms typical of thyrotoxicosis. There was no 
relevant past medical history. One week before hospitalisation 
she was found to have markedly elevated thyroid function 
tests with Free T4 >100 pmol/L (NR 11-21) and TSH <0.02 
mU/L  (NR  0.3-4.5)  and  had  commenced  treatment  with 
Carbimazole (40 mgs od) and Propanolol  (80 mgs b.d.).
On  admission  she  was  dyspnoeic  at  rest  with  a  sinus 
tachycardia. BP was 118/62. Bilateral pitting leg oedema, 
a  small  goitre  and  a  right  pleural  effusion  confirmed  on 
chest X-Ray were noted. Biochemically there was continued 
evidence  of  hyperthyroidism  -  FT4  34.9  and TSH  <0.02 
with positive anti-thyroid peroxidase antibodies; 215 IU/ml 
(NR 0-135). C-reactive protein (CRP) was raised at 109. An 
echocardiogram revealed normal left ventricular function and 
evidence of a small localised pericardial effusion. There was 
no pericardial tamponade at this time. Following continued 
treatment  with  beta-blockers  and  an  increased  dose  of 
Carbimazole (60 mgs o.d.) and diuretics the patient’s clinical 
condition improved and she was discharged.
Two  weeks  later  she  presented  with  further  respiratory 
distress and was noted to have a raised venous pressure and 
a  BP  of  84/60. Thyroid  function  tests  showed  continued 
improvement. Repeat CXR revealed cardiomegaly (Figure 
1). Repeat echocardiogram demonstrated a large pericardial 
effusion  (Figure  2).  The  patient  was  transferred  to  the 
regional cardiology centre where 275mls of blood stained 
fluid was drained from the pericardial space with immediate 
improvement in dyspnoea and blood pressure. Biochemically 
the fluid was an exudate; culture and cytology were negative. 
Following this she remained well.
Conclusions:  This  case  shows  that  pericardial  effusion 
resulting in tamponade can develop in Graves thyrotoxicosis 
even during anti-thyroid treatment and with improving thyroid 
function tests.
A Medline search over the last twenty years uncovered two 
other  reports  of  similar  cases  in  English  journals  with  a 
further report in a Japanese journal1-4. Authors from Oxford 
described a series of four patients all presenting with chest 
pain  and  effusions  as  the  predominant  manifestation  of 
otherwise occult Graves’ thyrotoxocosis.2 The most recent 
case report from Israel3 describes a patient who developed a 
pericardial effusion despite treatment of hyperthyroidism. In 
this case tamponade did not develop and pericardiocentesis 
was not required. The aetiology of these complications is 
unclear although the blood stained nature of the pericardial 
effusion and the preceding pain and raised CRP suggests 
an  inflammatory  pericarditis.  We  therefore  suggest  it 
would be prudent to exclude Graves’ thyrotoxicosis in any 
patient presenting with an unexplained pericardial effusion 
despite the absence of classical symptoms of thyrotoxicosis. 
Furthermore,  in  a  patient  with  active  Graves’  disease, 
symptoms  such  as  chest  pain  and  dyspnoea  need  to  be 
considered  as  potentially  heralding  the  development  of 
cardiac tamponade. While this complication is rare it may be 
rapidly fatal and thus go unrecognised and unreported. 
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Fig 2. Repeat echocardiogram confirming large pericardial 
effusion (arrowed).
Fig 1.  CXR on admission (left) showing a small pleural 
effusion and normal cardiac silhouette.  Repeat film 2 
weeks later (right) showing appearances in keeping with a 
pericardial effusion© The Ulster Medical Society, 2009.
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PATCHY SMALL BOWEL ISCHAEMIA 
SECONDARY TO SEPSIS
Editor,
Insufficient blood perfusion to the small bowel may result 
from arterial occlusion by embolus or thrombosis, thrombosis 
of the venous system, or non-occlusive processes such as 
vasospasm or low cardiac output.  Patterns of segmental, 
skipped, or patchy small bowel ischaemia have been reported 
post  abdominal  aortic  aneurysm  repair  and  is  thought  to 
imply that microembolisation has played an important role¹. 
Microvascular  thrombi  in  various  organs  can  result  from 
disseminated intravascular coagulation². We present a case 
of patchy small bowel ischaemia in a septic patient who had 
developed evidence of disseminated intravascular coagulation.
Case  presentation:  A  50-year-old  man  prescribed  four 
weeks of diclofenac for a muscular strain presented with 
frank haematemesis secondary to an eroding gastric ulcer 
measuring 7 cm in diameter. A partial gastrectomy and Roux-
en-Y  reconstruction  was  performed  and  a  massive  blood 
transfusion of 25 units was required peri-operatively.  The 
patient was referred to a tertiary care centre for intensive care 
where on day six post operatively, he developed peritonitis as 
a result of a biliary leak from his duodenal stump. His blood 
tests at that time were suggestive of non-overt disseminated 
intravascular coagulation secondary to sepsis with an elevated 
D-dimer  of  7.36  μg/ml  (0.01-0.5  μg/ml). An  emergency 
exploratory  laparotomy  was  performed.  This  revealed  a 
duodenal stump blowout and a 2 inch segment of proximal 
jejunum  containing  multiple  less  than  1  cm  blisters  in  a 
triangular arrangement (figure 1). These were found to be 
necrotic areas and were resected. Histology of the specimen 
confirmed  areas  of  transmural  haemorrhagic  ischaemic 
necrosis  associated  with  a  marked  serosal  exudate  and 
incipient perforation. Thrombi were histologically identified 
within the omentum. Later in the post-operative period he 
developed bleeding from his duodenal stump for which he had 
successful radio-embolisation of the gastroduodenal artery. 
After a complicated postoperative period, he was discharged 
home. Although, patchy bowel ischaemia has been reported 
in past, this pattern in a mid jejunal small bowel segment 
containing multiple less than 1 cm areas of necrosis in a septic 
patient has not been reported to our knowledge.
Discussion:  Patchy  small  bowel  ischaemia  has  been 
noted  in  patients  following  abdominal  aortic  aneurysm 
repair¹.  Some  of  these  patients  have  been  found  to  have 
widespread  microembolisation  or  to  have  pathological 
evidence of microemboli.  As a result it has been postulated 
that  this  pattern  of  ischaemia  is  a  direct  consequence  of 
microembolisation3.  Sepsis  almost  invariably  leads  to 
haemostatic abnormalities.  These range from the insignificant 
to severe disseminated intravascular coagulation.  Compelling 
evidence  from  clinical  and  experimental  studies  suggests 
that disseminated intravascular coagulation is involved in the 
pathogenesis of microvascular dysfunction and that deposition 
of  microvascular  thrombi  can  occur3,4.    Given  the  above 
patient had an elevated D-dimer and evidence of thrombi on 
histology it is our feeling that the likely mechanism behind 
this unusual intra-operative finding was microembolisation. 
With sepsis related disseminated intravascular coagulation 
being the most likely cause.
Conclusions: We conclude that in septic patients, the bowel 
should be carefully examined as missing such pathology will 
have serious implications for critically ill surgical patients.
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CLINICAL EXPERIENCE WITH INTRAVENOUS 
IMMUNOGLOBULIN AND TNF-Α INHIBITOR 
THERAPIES FOR RECURRENT PREGNANCY LOSS
Editor,
We report on a 22 year-old non-smoking nulligravida who 
presented with her husband for in vitro fertilisation (IVF). She 
was in good general health and had five prior unsuccessful 
IVF treatments, all with implantation failure. While her TSH 
and T4 were normal, a strongly positive (1:25,600) thyroid 
peroxidase antibody (ATA) titre was noted. Their sixth IVF 
cycle included IVIG infusion x3 as had been used in the 
immediately preceding cycle. However, etanercept (Enbrel®;  Fig 1. Proximal jejunum with multiple necrotic areas